the aclaris therapeutics ( n=7 ) company is a tertiary care hospital in the united states. it has been a major breakthrough in the treatment of dermatology. in this article, we present the results of the second quarter of the year and discuss the current status of our products and their clinical development programs. we also provide an overview of the financial results of the year and the current status of our products.